Rare condition

Turner syndrome due to structural X chromosome anomalies

ORPHA:99413 ↗Etiological subtype

0

studies recruiting now

as of 7 Sept 2026

0

studies registered in total

as of 7 Sept 2026

0

countries with a recruiting site

as of 7 Sept 2026

None

recruiting study posted to date

among recruiting studies

Recruiting trials

No registered studies found for Turner syndrome due to structural X chromosome anomalies.

ClinicalTrials.gov has no study listed under this name as of 7 Sept 2026. That can change, and there are other routes worth knowing about.

Keep watching

Get an email when a new Turner syndrome due to structural X chromosome anomalies study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Turner syndrome due to structural X chromosome anomalies

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Treatments being studied

1 approved treatment and 6 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Somatropin (Genotropin)
Phase 3Lonapegsomatropin (Skytrofa)
Phase 3Ethinyl Estradiol (Estinyl)
Phase 3Estradiol (Adgyn estro)
Phase 3Medroxyprogesterone Acetate (Adgyn medro)
Phase 2Somatropin Pegol
Phase 2Oxandrolone (Anavar)

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).